Retrospective analysis of the role of intra-operative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism: a single center experience over 2 decades

Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5375-5380. doi: 10.1007/s00405-022-07440-5. Epub 2022 Jun 29.

Abstract

Purpose: Role of intra-operative parathyroid hormone (IOPTH) monitoring during parathyroidectomy for primary hyperparathyroidism (PHPT) has long been debated. Our main goal was to investigate the cure rates of parathyroidectomy for primary hyperparathyroidism with and without IOPTH monitoring. Our secondary goal was to investigate if operating room time can be saved when IOPTH monitoring is not used.

Methods: A retrospective analysis of patients who underwent parathyroidectomy for PHPT due to a single adenoma between 2004 and 2019 was performed. Cure rates and operating room time were compared.

Results: 423 patients were included. IOPTH was used in 248 patients (59%). Four patients were not cured, two from each group, with no significant difference between the groups (98.8% vs. 99.1%, p = 0.725). Surgery time was significantly longer in the IOPTH group, p < 0.001.

Conclusions: There is no advantage for using IOPTH during parathyroidectomy in suitable clinical settings. The procedure may be safely performed without IOPTH while achieving non-inferior success rates and reducing operative time.

Keywords: Intra-operative parathyroid hormone monitoring; Operative time; Parathyroid adenoma; Parathyroidectomy; Primary hyperparathyroidism.

MeSH terms

  • Humans
  • Hyperparathyroidism, Primary* / surgery
  • Monitoring, Intraoperative / methods
  • Parathyroid Hormone
  • Parathyroidectomy* / methods
  • Retrospective Studies

Substances

  • Parathyroid Hormone